This device is currently undergoing FDA review and is not commercially available for sale in the U.S.
In a field as important as resuscitation, directly impacting hundreds of thousands of people and countless friends, relatives, and community members annually in the United States, it’s noteworthy that there has been limited innovation. Consequently, rates of surviving out of hospital cardiac arrest have remained stubbornly stagnant.
According to Sameer Jafri, President of Avive Solutions, the technological innovations we have seen have been more suited to the professional market, not lay responders.
“Great improvements have been made with EMS and hospital technology, but with public access defibrillators, incremental new features have been met with increased cost,” says Jafri. “We feel like there’s a disconnect between where the problem most often resides, who can meaningfully help solve it, and where the industry seems to focus most of its time.”
Click here to visit Avive’s website and watch a video to see their re-imagined AED solution.
Avive’s view is that defibrillation works and, therefore, doesn’t need to be reinvented. Instead, it’s the delivery of early bystander defibrillation that has posed the most significant challenge to improving outcomes.
“While having an AED is great, it doesn’t do responders any good if they don’t know it needs to be used. So, we decided to build a first-of-its-kind solution in which the Avive Connect AED tells people nearby exactly when and where it needs to be to save a life!” says Jafri.
While Avive’s new AED is still in the FDA review process, check out the video above to see how Avive is reimagining the future of sudden cardiac arrest response.
If you’re interested in learning more about Avive, check out their website, or contact them here.
SOURCE: Avive Solutions